Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2000
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275164A Neisseria lactoferrin binding protein
11/29/2000CN1275163A Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner
11/29/2000CN1275161A Monoclonal antibody 3-6-A specific to surface of dendritic cells among the peripheral blood leukocytes
11/28/2000US6153814 Polypeptide compositions toxic to lepidopteran insects and methods for making same
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153409 Simple, efficient method by adding baculovirus vector which codes for protein of interest and green fluorescent protein to insect larvae food, feeding to insect larvae, monitoring for gene expression, harvesting, recovering protein
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
11/28/2000US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics
11/28/2000US6153404 Regulatory sequence linked to sequence coding for a heterologous polypeptide; for controlled/inducible gene expression in recombinant system
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153395 ICAM-related protein
11/28/2000US6153391 Contacting p53 and oncoprotein with a peptide fragment or analogue including a defined amino acid sequence or an organic molecule having three-dimensional structure of that amino acid sequence; interferes with binding
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153377 Synthetic DNA derived recombinant HIV antigens
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000US6153191 Giardia treatment and antibody
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000US6153187 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
11/28/2000US6153183 A modified human interleukin-3 polypeptide, comprises the replacement of 6 to about 44 residues at positions 17-118 of native interleukin-3 by other amino acids with the proviso that asparagine at position 101 and lysine at position 116
11/28/2000CA2308259A1 Method for assaying the function of flaa1 and wbpm
11/28/2000CA2305716A1 Method for assay of wbpm
11/28/2000CA2091243C Recombinant acc synthase
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/27/2000CA2307327A1 Process for the preparation of l-amino acids by fermentation and nucleotide sequences coding for the accda gene
11/23/2000WO2000070100A1 Surface display of selenocysteine-containing peptides
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070048A1 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING MURINE ORGANIC ANION TRANSPORTER 6 (mOATP6) AND SCREENING METHODS THEREOF
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070023A1 Novel fab fragment libraries and methods for their use
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069909A1 Isolation and characterization of epidermal growth factor related protein
11/23/2000WO2000069907A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069886A2 Oligomeric chaperone proteins
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000046375A3 Methods for producing polypeptides in fungal cells
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000042560A3 Methods for making character strings, polynucleotides and polypeptides
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374045A1 Compositions isolated from skin cells and methods for their use
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372582A1 Novel fab fragment libraries and methods for their use
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372435A1 Recombinant human mannan-binding lectin
11/23/2000CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2372199A1 Oligomeric chaperone proteins
11/23/2000CA2372198A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2369397A1 Combined approach to treatment of cancer with hcg vaccines
11/23/2000CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/22/2000EP1054063A2 Process for the production of naturally folded and secreted proteins
11/22/2000EP1054018A1 Fab fragment libraries and methods for their use
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053341A1 Use of negative regulation elements for nerve-specific expression of transgenes
11/22/2000EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
11/22/2000EP1053324A1 Novel cystine knot protein and materials and methods for making it
1 ... 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 ... 1125